Insider trades
Boulding Mark Elliott, CLO of PTC Therapeutics PTCT, has filed 0 purchases and 91 sales on the open market. Over the past 12 months that comes to a net sale of $5.3M. The latest trade was on 06/17.
Boulding Mark Elliott
Exec. Vp and Clo
- Company
- PTC Therapeutics PTCT
- First filing
- 23/01/09
- Trades
- 178 trades
- Buys / sales
- 0 / 91
- 12-month net buying
- −$5.3M
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PTCT | Open-market sale10b5-1 plan | 06/17 | 06/22 | 10,462 sh4 trades | $78.65avg. | $822,867.75 | −9.0% |
PTCT | Open-market sale10b5-1 plan | 05/15 | 05/19 | 2,812 sh2 trades | $72.18avg. | $202,958 | −2.6% |
PTCT | Open-market sale10b5-1 plan | 05/08 | 05/12 | 3,540 sh4 trades | $78.97avg. | $279,570.2 | −3.3% |
PTCT | Open-market sale10b5-1 plan | 04/06 | 04/08 | 2,265 sh2 trades | $69.45avg. | $157,293.27 | −2.1% |
PTCT | Open-market sale10b5-1 plan | 02/19 | 02/23 | 3,019 sh4 trades | $69.48avg. | $209,762.58 | −2.8% |
PTCT | Open-market sale10b5-1 plan | 02/17–02/18 | 02/19 | 5,894 sh3 trades | $69.33avg. | $408,612.61 | −5.2% |
PTCT | Open-market sale10b5-1 plan | 01/08–01/09 | 01/12 | 6,347 sh6 trades | $77.06avg. | $489,080.53 | −5.4% |
PTCT | Open-market sale10b5-1 plan | 01/06–01/07 | 01/08 | 6,618 sh8 trades | $77.31avg. | $511,641.42 | −5.3% |
PTCT | Open-market sale10b5-1 plan | 01/05 | 01/06 | 2,266 sh3 trades | $75.55avg. | $171,191.98 | −1.8% |
PTCT | Open-market sale10b5-1 plan | 25/11/17 | 25/11/19 | 2,812 sh3 trades | $75.99avg. | $213,686.89 | −2.6% |
PTCT | Open-market sale10b5-1 plan | 25/10/07 | 25/10/09 | 3,375 sh3 trades | $63.43avg. | $214,091.17 | −3.1% |
PTCT | Open-market sale10b5-1 plan | 25/10/03–25/10/06 | 25/10/07 | 24,921 sh11 trades | $65.75avg. | $1,638,548.63 | −19.3% |
PTCT | Open-market sale10b5-1 plan | 25/09/11–25/09/12 | 25/09/15 | 47,249 sh7 trades | $61.18avg. | $2,890,586.51 | −31.3% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 25/08/15 | 25/08/19 | 2,813 sh | $48.58 | $136,655.54 | −2.6% |
PTCT | Open-market sale | 25/05/15–25/05/16 | 25/05/19 | 2,812 sh2 trades | $46.13avg. | $129,716.88 | −2.6% |
PTCT | Open-market sale10b5-1 plan | 25/03/12 | 25/03/14 | 15,521 sh2 trades | $53.30avg. | $827,232.91 | −13.0% |
PTCT | Open-market sale10b5-1 plan | 25/03/10–25/03/11 | 25/03/12 | 75,420 sh6 trades | $53.08avg. | $4,003,304.97 | −42.1% |
PTCT | Open-market sale10b5-1 plan | 25/02/19–25/02/20 | 25/02/21 | 2,947 sh2 trades | $50.11avg. | $147,676.98 | −2.8% |
PTCT | Open-market sale10b5-1 plan | 25/01/07–25/01/08 | 25/01/10 | 3,541 sh2 trades | $44.87avg. | $158,870.62 | −3.2% |
PTCT | Open-market sale10b5-1 plan | 24/12/02–24/12/03 | 24/12/04 | 95,908 sh7 trades | $52.37avg. | $5,022,334.27 | −50.9% |